Results for tag: "Spondyloarthritis Drug"

The Spondyloarthritis Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for chronic inflammatory diseases. Spondyloarthritis is a type of inflammatory arthritis that affects the spine and other joints, and is characterized by pain, stiffness, and swelling. Common treatments for spondyloarthritis include non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), and biologic drugs. NSAIDs are used to reduce pain and inflammation, while DMARDs and biologics are used to slow the progression of the disease. Some companies in the Spondyloarthritis Drug market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Novartis, Pfizer, and UCB. Show Less Read more